U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07810972) titled 'Evaluate the Safety and Efficacy of TJO-087' on Sept. 02.
Brief Summary: This study aims to evaluate the therapeutic efficacy and safety of investigational product compared with placebo in adult patients with dry eye disease. Patients will receive investigational product or placebo for 3 months, and the therapeutic effect will be assessed based on the change in corneal staining score from baseline.
Study Start Date: April 06
Study Type: INTERVENTIONAL
Condition:
Dry Eye Syndrome (DES)
Intervention:
DRUG: TJO-087
one drop in each eye, twice daily (1 drop of IP, 1 drop of placebo)
DRUG: TJO-087
one drop in each eye, twice da...